Breast Imaging

Women's health related to breast imaging, including mammography, breast MRI, ABUS, automated breast ultrasound, breast ultrasound, breast biopsy, PEM and positron emission mammography.

Prelude Corporation (PreludeDx), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced that the American Medical Association (AMA) has issued a new, dedicated current procedural terminology (CPT) proprietary laboratory analyses (PLA) code for DCISionRT, the only test available to predict personalized recurrence risk and radiation therapy benefit for patients with ductal carcinoma in situ (DCIS).
News | Radiation Oncology
American Medical Association Grants PreludeDx a CPT PLA Code for Proprietary DCISionRT Test

November 12, 2021 — Prelude Corporation (PreludeDx), a leader in molecular diagnostics and precision medicine for early ...

Time November 12, 2021
arrow
Breast Density Standard
News | Breast Density
DenseBreast-info.org Commemorates 10-Year Anniversary of FDA Breast Density Inform Consensus

November 10, 2021 — DenseBreast-info.org (DB-I) commemorates the 10-year anniversary of the FDA’s National Mammography ...

Time November 10, 2021
arrow
Breast density scale showing the varying degrees of breast density.
Feature | Breast Density | By Robert L. Bard, M.D. DABR, FASL and Noelle Cutter, Ph.D.
Dense Breast Imaging Detection and Image-guided Oncologic Treatment

Prologue In 2014, Imaging Technology News (ITN) introduced breast cancer survivor-turned-crusader Nancy Cappello, Ph.D ...

Time November 09, 2021
arrow
Data presented demonstrates use of DCISionRT and its response subtype (Rst) was able to identify women with ductal carcinoma in situ (DCIS)  (Stage 0 breast cancer) who remain at an elevated risk of recurrence despite receiving breast conserving surgery (BCS) and radiation therapy (RT).
News | Radiation Therapy
PreludeDx Presents DCIS Precision Medicine Study Results at ASTRO 2021 Annual Meeting

November 2, 2021 — Prelude Corporation, a leader in molecular diagnostics and precision medicine for early-stage breast ...

Time November 02, 2021
arrow
Koning begins an FDA screening trial this month for their no-compression, Isotropic, 3-dimensional breast imaging device. The company received FDA PMA approval for commercial, diagnostic use in 2017
News | Breast Imaging
Koning Begins FDA Clinical Screening Trial in Daytona Beach

November 1, 2021 — Koning begins an FDA screening trial this month for their no-compression, Isotropic, 3-dimensional ...

Time November 01, 2021
arrow
News | Mammography
Penn Medicine, Siemens Healthineers Offer Mobile 3D Mammography Screenings for Underserved Patients

October 27, 2021 — As part of Breast Cancer Awareness Month, Penn Medicine will be providing free breast cancer ...

Time October 27, 2021
arrow
In conjunction with ongoing Breast Cancer Awareness Month efforts, Hologic, Inc., an innovative medical technology company primarily focused on improving women’s health, unveiled Carolina, a narrative documentary-style film about the breast cancer journey from diagnosis to reconstruction, developed in collaboration with Mediflix and Moonlight Productions.
News | Women's Health
Hologic Debuts Documentary-Style Film Highlighting One Woman's Breast Cancer Journey Timed to Breast Reconstruction Awareness Day

October 20, 2021 — In conjunction with ongoing Breast Cancer Awareness Month efforts, Hologic, Inc., an innovative ...

Time October 20, 2021
arrow
If Black women begin mammography screening every other year starting at age 40, breast cancer deaths could be reduced by 57 percent compared to starting screening 10 years later — as is currently recommended by some organizations — according to analyses conducted by a modeling team that is part of the Cancer Intervention and Surveillance Modeling Network (CISNET), funded by the National Cancer Institute. #mammography
News | Mammography
Starting Mammography at Age 40 Would Reduce Disparities in Deaths for Black Women

October 19, 2021 — If Black women begin mammography screening every other year starting at age 40, breast cancer deaths ...

Time October 19, 2021
arrow
MR images showing reduction in size of metastatic tumors after focused-ultrasound delivery of antibody therapy through blood-brain barrier.
News | Ultrasound Women's Health
World-first Clinical Trial Demonstrates Focused Ultrasound Can Deliver Antibody Therapy to Breast Cancer Metastases in the Brain

October 14, 2021 — In a first-in-world clinical trial, researchers at Sunnybrook Health Sciences Centre in Toronto ...

Time October 14, 2021
arrow
Delphinus Medical Technologies, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) of its SoftVue 3D Whole Breast Ultrasound Tomography System (SoftVue) for use as an adjunct to digital mammography in the screening of asymptomatic women with dense breast tissue.
News | Breast Imaging
Delphinus Receives FDA Approval for its SoftVue 3D Whole Breast Ultrasound Tomography System

October 14, 2021 — Delphinus Medical Technologies, Inc. announced that the U.S. Food and Drug Administration (FDA) has ...

Time October 14, 2021
arrow
Magda El-Shenawee, University of Arkansas breast cancer research
News | Women's Health
NIH Grant Will Further Researcher’s Work Detecting Breast Cancer

October 11, 2021 — Electrical engineering professor Magda El-Shenawee’s effort to develop a more accurate and less ...

Time October 11, 2021
arrow
An analysis of nearly 200,000 patients highlights the heterogeneity of breast cancer risk factors for women of differing races, ages, and disease subtypes
News | Women's Health
Black Women Face Three-fold Increased Risk of Triple Negative Breast Cancers

October 8, 2021 — An analysis of nearly 200,000 patients who received mammograms between 2006 and 2015 across three U.S ...

Time October 08, 2021
arrow
An automated system that uses artificial intelligence (AI) can quickly and accurately sift through breast MRIs in women with dense breasts to eliminate those without cancer, freeing up radiologists to focus on more complex cases, according to a study published in Radiology.
News | MRI Breast
AI Helps Rule Out Cancer in Dense Breasts

October 7, 2021 — An automated system that uses artificial intelligence (AI) can quickly and accurately sift through ...

Time October 07, 2021
arrow
A commentary by Mayo Clinic Cancer Center researchers published in the Journal of Clinical Oncology Practice suggests that advances in breast cancer prevention research have resulted in new and innovative opportunities to modify breast cancer risk and potentially reduce breast cancer incidence and mortality.
News | Women's Health
Mayo Clinic Researchers Advocate New Approach to Breast Cancer Prevention

October 6, 2021 — A commentary by Mayo Clinic Cancer Center researchers published in the Journal of Clinical Oncology ...

Time October 06, 2021
arrow
Images of uptake in bone metastasis in patient 2. Anterior whole-body (left) and SPECT/CT (right) images show uptake of 131I-GMIB-anti-HER2-VHH1 at level of large lytic bone metastasis, with soft-tissue component at sternal bone both at 2.5 h and at 24 h after injection. Small differences in area of uptake are explained by differences in patient positioning (arms up at 2.5 h and arms down at 24 h, to maximize patient comfort). Cts = counts. Image created by M. Keyaerts, University Hospital of Brussels (UZ B
News | Women's Health
New Radionuclide Therapy Identified for HER2-positive Breast Cancer Patients

October 5, 2021 — A promising radionuclide treatment may offer new therapeutic options for breast cancer patients ...

Time October 05, 2021
arrow
Hologic, Inc., an innovative medical technology company primarily focused on improving women’s health, announced today that CEO Steve MacMillan will ring the Nasdaq opening bell on October 4 to mark the beginning of Breast Cancer Awareness Month.
News | Women's Health
Hologic Rings Nasdaq Opening Bell for 15th Time to Kick Off Breast Cancer Awareness Month
October 4, 2021 — Hologic, Inc., an innovative medical technology company primarily focused on improving women’s health ...
Time October 04, 2021
arrow
Determination of ER status of disease. In 59-y-old woman diagnosed with ER-positive lobular BC 2 y previously and treated with tamoxifen, ER-positive bone metastases were identified 1 y after initial diagnosis.
News | Breast Imaging
Newly Approved PET Imaging Agent Solves Clinical Dilemmas in Breast Cancer Patients
October 4, 2021 — A non-invasive, patient-friendly imaging technique can help physicians make treatment decisions for ...
Time October 04, 2021
arrow
According to the American Cancer Society, around 10-15% of breast cancers are triple-negative breast cancer.
News | Breast Imaging
Georgia Cancer Center Researcher Receives $1.7M Grant to Study Aggressive Form of Breast Cancer 
October 4, 2021 — Understanding the role a certain molecule plays in both cancer cells, as well as the cells tasked to ...
Time
arrow
A new paper in the Journal of the National Cancer Institute, published by Oxford University Press, indicates that magnetic resonance imaging (MRI) is cost-effective for detecting breast cancer for women with very dense breasts detected by mammography.
News | MRI Breast
MRIs are Cost-effective for Detecting Breast Cancer in Women with Dense Breasts
October 4, 2021 — A new paper in the Journal of the National Cancer Institute, published by Oxford University Press ...
Time
arrow
September 28, 2021 — A computer program trained to see patterns among thousands of breast ultrasound images can aid physicians in accurately diagnosing breast cancer, a new study shows.
News | Breast Imaging
Artificial Intelligence Tool Improves Accuracy of Breast Cancer Imaging

September 28, 2021 — A computer program trained to see patterns among thousands of breast ultrasound images can aid ...

Time September 28, 2021
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now